Damian Marron

Damian Marron has a broad range of experience in the life sciences industry. In 2021, they began serving as a Non Executive Director for Cantargia AB. In 2020, they took on the role of Chair of the Board of Directors for Targovax ASA and CytoSeek, and also became a Non Executive Director for Imophoron Ltd. In 2018, they became a Non Executive Director for Resolys Bio. In 2017, they took on the role of Non Executive Director for BONE THERAPEUTICS S.A. and in 2018, they became Chair of the Board of Directors for PepGen. From 2016-2018, they were Head of Biopharma for Treehill Partners Limited. Finally, from 2015-2017, they served as both a Member Board of Directors and Chief Executive Officer for Agalimmune, and from 2014-2015, they were a Board Director for France Biotech.

Damian Marron attended the University of Liverpool from 1982 to 1985, where they earned a Bachelor of Science (BSc) in Pharmacology.